IDEXX Launches 100% Direct Ordering in the U.S. Two Months Early
Customer benefits include free shipping, next-day delivery, full credit for expired product, and up to 20% off select gold-standard in-house diagnostics
WESTBROOK, Maine, October 27, 2014—IDEXX Laboratories, Inc. (NASDAQ: IDXX) today announced that customers may begin ordering 100% of IDEXX’s products directly from the company in the US. IDEXX direct ordering is available today, approximately two months ahead of schedule. Customers may call 1-888-79-IDEXX or contact their IDEXX representative directly to place orders.
“The most effective way for IDEXX to help our customers deliver high-quality care and grow their practice is to provide a knowledgeable source for diagnostic product expertise and ordering,” said George Fennell, corporate vice president, IDEXX. “Going direct in the U.S. is just one part of a bigger initiative we’re undertaking to deliver greater value to our customers by expanding support and services that they value most. As part of this strategy, we are increasing by 50% the number of IDEXX professionals available to support our customers and their use of our diagnostic products and services to meet their patient care needs and practice goals.”
Customers ordering direct from IDEXX in the U.S. will have immediate access to a number of valuable benefits:
- Free shipping
- Next-day delivery via UPS® and FedEx® to the entire continental U.S.
- For loyal customers, full credit for unopened, expired products purchased directly from IDEXX
- A 20% discount on select chemistry tests for use on the Catalyst Dx®, Catalyst One™ and VetTest® chemistry analyzers when purchased with a profile, through March 31, 2015
- The benefit of our IDEXX SNAP Up The Savings™ program, which provides customers who enroll in 2014 up to 10% off all SNAP® diagnostic tests in 2014. Customer enrollees can continue to earn 10% savings on all direct orders for the full 2015 calendar year with a combination of up-front discounts and year-end rebates.
“We’re pleased to be ahead of schedule in offering the wealth of services that our U.S. direct ordering model provides to customers,” said Fennell. “It’s our mission to support the growth and relevance of the veterinary profession. Consistent with that goal, the team at IDEXX is now able to provide a world-class ordering experience.”
As part of its direct sales shift, IDEXX has made a significant investment in new teams dedicated to working one-on-one with practices to help them address their specific practice needs. This includes expanded teams of veterinary diagnostic consultants, field service representatives, professional service veterinarians and inside sales representatives.
To ensure a smooth transition for customers, IDEXX will also continue working with its U.S. distributors through the end of 2014.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing livestock and poultry diagnostic tests and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 6,000 people and offers products to customers in more than 175 countries.
Note Regarding Forward-Looking Statements
This trade release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “expects,” “may,” “anticipates,” “intends,” “would,” “will,” “plans,” “believes,” “estimates,” “should,” and similar words and expressions. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company's filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at www.sec.gov, at various SEC reference facilities in the United States and via the Company’s website at www.idexx.com).
IDEXX Laboratories, Inc.